Posted On: 05/17/2017 9:21:27 PM Posted By: plutonium

New Post Public Reply Private Reply Replies (0) Message Board
weaver_525
273
Quote:
Posted On: 05/17/2017 9:21:27 PM

Posted By: plutonium


Re: chemist823 #579

In my humble opinion, and sitting here at 4:15 am, I think the company will choose to uplist via the OTCMarkets program, and keep the M&A transaction on the back burner but not out of mind until the OTCMarkets offer is played out. The M&A transaction is not only expensive but it will take 9-11 months to complete the S-4 registration with the SEC. The iHub complainers will gripe about that too and make it sound like DECN is at fault that the SEC is methodical.

Uplisting for $12,500.00 ($2,500.00 application fee, and $10,000.00 listing fee) is a lot cheaper (and immediate if DECN is approved) than a merger with a non-shell shell, what with legal fees, SEC registration statement costs, stock distribution fees etc. But this is only my opinion.

I know that people on the iHub board will hate all of this because it could take away their pop-guns, so they will have to find something else to complain about -- and they will.






How did the uplisting go?
1

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Dell Technologies: A Fresh Look at Investor Sentiment Trends

Updated Category News Views 285

Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...

Continue Reading
Compass Diversified Faces Investigation for Securities Violations

Updated Category News Views 173

Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...

Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities

Updated Category News Views 226

Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...

Continue Reading
Growth Prospects of the Global Medical Imaging Reagents Market

Updated Category News Views 148

Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...

Continue Reading
Mike Tyson Teams Up with GBank Financial in New Venture

Updated Category News Views 285

GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...

Continue Reading